Select Publications

Journal articles

Lum A; Donnan B; Wakefield CE; Fardell JE; Marshall GM, 2017, 'Establishing Australian school re-entry service guidelines for children diagnosed with cancer', Journal of Paediatrics and Child Health, 53, pp. 529 - 533, http://dx.doi.org/10.1111/jpc.13563

Signorelli C; Wakefield CE; Fardell JE; Wallace WHB; Robertson EG; McLoone JK; Cohn RJ, 2017, 'The impact of long-term follow-up care for childhood cancer survivors: A systematic review', Critical Reviews in Oncology Hematology, 114, pp. 131 - 138, http://dx.doi.org/10.1016/j.critrevonc.2017.04.007

Fardell JE; Wakefield CE; Signorelli C; Hill R; Skeen J; Maguire AM; McLoone JK; Cohn RJ; Alvaro F; Corbett R; Downie P; Egan K; Ellis S; Foreman T; Gabriel M; Girgis A; Graham K; Johnston K; Jones J; Lockwood L; McCarthy M; Molloy S; Osborn M; Tapp H; Till T; Truscott J; Turpin K; Walwyn T; Yallop K, 2017, 'Transition of childhood cancer survivors to adult care: The survivor perspective', Pediatric Blood and Cancer, 64, http://dx.doi.org/10.1002/pbc.26354

Wakefield CE; Fardell JE; Doolan EL; Aaronson NK; Jacobsen PB; Cohn RJ; King M, 2017, 'Participation in psychosocial oncology and quality-of-life research: a systematic review', Lancet Oncology, 18, pp. e153 - e165, http://dx.doi.org/10.1016/S1470-2045(17)30100-6

Gan LL; Lum A; Wakefield CE; Nandakumar B; Fardell JE, 2017, 'School Experiences of Siblings of Children with Chronic Illness: A Systematic Literature Review', Journal of Pediatric Nursing, 33, pp. 23 - 32, http://dx.doi.org/10.1016/j.pedn.2016.11.007

Vetsch J; Fardell JE; Wakefield CE; Signorelli C; Michel G; McLoone JK; Walwyn T; Tapp H; Truscott J; Cohn RJ, 2017, '“Forewarned and forearmed”: Long-term childhood cancer survivors’ and parents’ information needs and implications for survivorship models of care', Patient Education and Counseling, 100, pp. 355 - 363, http://dx.doi.org/10.1016/j.pec.2016.09.013

Wakefield CE; Fardell JE; Doolan EL; Drew D; De Abreu Lourenco R; Young AL; Cohn RJ, 2017, 'Grandparents of children with cancer: Quality of life, medication and hospitalizations', Pediatric Blood and Cancer, 64, pp. 163 - 171, http://dx.doi.org/10.1002/pbc.26153

Mizrahi D; Wakefield CE; Fardell JE; Quinn VF; Lim Q; Clifford BK; Simar D; Ness KK; Cohn RJ, 2017, 'Distance-delivered physical activity interventions for childhood cancer survivors: A systematic review and meta-analysis.', Crit Rev Oncol Hematol, 118, pp. 27 - 41, http://dx.doi.org/10.1016/j.critrevonc.2017.08.008

Georgiou G; Wakefield CE; McGill BC; Fardell JE; Signorelli C; Hanlon L; Tucker K; Patenaude AF; Cohn RJ, 2016, 'Genetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay', Cancer, 122, pp. 2876 - 2885, http://dx.doi.org/10.1002/cncr.30119

Wakefield C; Lin S; Drew D; McLoone J; Doolan E; Young A; Fardell J; Cohn R; Drew D; McLoone J, 2016, 'Development and Evaluation of an Information Booklet for Grandparents of Children With Cancer', Journal of Pediatric Oncology Nursing, 33, pp. 361 - 369, http://dx.doi.org/10.1177/1043454215602689

Fardell JE; Thewes B; Turner J; Gilchrist J; Sharpe L; Smith AB; Girgis A; Butow P, 2016, 'Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation', Journal of Cancer Survivorship, 10, pp. 663 - 673, http://dx.doi.org/10.1007/s11764-015-0512-5

Price MA; Butow PN; Bell ML; deFazio A; Friedlander M; Fardell JE; Protani MM; Webb PM; AOCS—Quality of Life Study Investigators on behalf of the Australian Ovarian Cancer Study Group , 2016, 'Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?', Supportive Care in Cancer, 24, pp. 2627 - 2634, http://dx.doi.org/10.1007/s00520-015-3070-5

Russo S; Fardell JE; Signorelli C; Wakefield CE; Mcloone JK; Cohn RJ, 2016, 'Sleep Disturbances in Childhood Cancer Survivors', Pediatric Blood and Cancer, 63, pp. 759 - 760, http://dx.doi.org/10.1002/pbc.25858

Costa DSJ; Smith A; Fardell JE, 2016, 'The sum of all fears: conceptual challenges with measuring fear of cancer recurrence', Supportive Care in Cancer, 24, pp. 1 - 3, http://dx.doi.org/10.1007/s00520-015-2943-y

Costa DSJ; Smith AB; Lim BT; Fardell JE, 2015, 'Simplifying the assessment of cancer information overload: A comment on Jensen et al. (2014)', Patient Education and Counseling, 98, pp. 1450, http://dx.doi.org/10.1016/j.pec.2015.04.020

Costa DSJ; Smith A; Fardell JE, 2015, 'The sum of all fears: conceptual challenges with measuring fear of cancer recurrence', Supportive Care in Cancer, http://dx.doi.org/10.1007/s00520-015-2943-y

Fardell JE; Vardy J; Monds LA; Johnston IN, 2015, 'The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy', Behavioural Brain Research, 291, pp. 80 - 88, http://dx.doi.org/10.1016/j.bbr.2015.04.038

Ben Smith A; Thewes B; Turner J; Gilchrist J; Fardell J; Sharpe L; Bell ML; Girgis A; Grier M; Byrne D; Clutton S; Butow P, 2015, 'Pilot of a theoretically grounded psychologist-delivered intervention for fear of cancer recurrence (Conquer Fear)', Psycho Oncology, 24, pp. 967 - 970, http://dx.doi.org/10.1002/pon.3775

Butow PN; Fardell JE; Smith AB, 2015, 'Fear of cancer recurrence: An overview and Australian perspective', Cancer Forum, 39, pp. 95 - 100

Noll KR; Fardell J, 2015, 'Comment on “Neuropsychological assessment of individuals with brain tumor: comparison of approaches used in the classification of impairment”', Frontiers in Oncology, 5, pp. 137, http://dx.doi.org/10.3389/fonc.2015.00137

Noll KR; Fardell JE, 2015, 'Commentary: "Neuropsychological assessment of individuals with brain tumor: Comparison of approaches used in the classification of impairment"', Frontiers in Oncology, 5, http://dx.doi.org/10.3389/fonc.2015.00188

Fardell JE; Zhang J; De Souza R; Vardy J; Johnston I; Allen C; Henderson J; Piquette-Miller M, 2014, 'The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice', Psychopharmacology, 231, pp. 841 - 852, http://dx.doi.org/10.1007/s00213-013-3301-8

Price MA; Butow PN; Bell ML; Webb PM; deFazio A; Friedlander M; Fardell JE, 2013, 'PSYCHOSOCIAL PREDICTORS OF SURVIVAL IN WOMEN WITH INVASIVE OVARIAN CANCER: A POPULATION-BASED PROSPECTIVE STUDY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 9, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fardell JE; Vardy J; Johnston IN, 2013, 'The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory', Life Sciences, 93, pp. 596 - 604, http://dx.doi.org/10.1016/j.lfs.2013.05.006

Butow PN; Bell ML; Smith AB; Fardell JE; Thewes B; Turner J; Gilchrist J; Beith J; Girgis A; Sharpe L; Shih S; Mihalopoulos C, 2013, 'Conquer fear: Protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence', BMC Cancer, 13, http://dx.doi.org/10.1186/1471-2407-13-201

Hicks C; Jorgensen W; Brown C; Fardell J; Koehbach J; Gruber CW; Kassiou M; Hunt GE; Mcgregor IS, 2012, 'The Nonpeptide Oxytocin Receptor Agonist WAY 267,464: Receptor-Binding Profile, Prosocial Effects and Distribution of c-Fos Expression in Adolescent Rats', Journal of Neuroendocrinology, 24, pp. 1012 - 1029, http://dx.doi.org/10.1111/j.1365-2826.2012.02311.x

Fardell JE; Vardy J; Shah JD; Johnston IN, 2012, 'Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity', Psychopharmacology, 220, pp. 183 - 193, http://dx.doi.org/10.1007/s00213-011-2466-2

Sharpe MJ; Fardell JE; Vardy JL; Johnston IN, 2012, 'The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats', Behavioural Brain Research, 227, pp. 295 - 299, http://dx.doi.org/10.1016/j.bbr.2011.11.0

Fardell JE; Vardy J; Johnston IN; Winocur G, 2011, 'Chemotherapy and cognitive impairment: Treatment options', Clinical Pharmacology and Therapeutics, 90, pp. 366 - 376, http://dx.doi.org/10.1038/clpt.2011.112

Seigers R; Fardell JE, 2011, 'Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research', Neuroscience and Biobehavioral Reviews, 35, pp. 729 - 741, http://dx.doi.org/10.1016/j.neubiorev.2010.09.006

Price MA; Butow PN; Costa DSJ; King MT; Aldridge LJ; Fardell JE; DeFazio A; Webb PM, 2011, 'MJA: Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their carergivers', The Medical Journal of Australia, 195, pp. 232 - 232, http://dx.doi.org/10.5694/j.1326-5377.2011.tb03294.x

Fardell JE; Vardy J; Logge W; Johnston I, 2010, 'Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents', Pharmacology Biochemistry and Behavior, 97, pp. 333 - 339, http://dx.doi.org/10.1016/j.pbb.2010.08.019

Price MA; Butow PN; Costa DSJ; King MT; Aldridge LJ; Fardell JE; deFazio A; Webb PM, 2010, 'Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers', Medical Journal of Australia, 193, pp. S52 - S57, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03929.x


Back to profile page